BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$478M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Alibaba
BABA
|
+$295M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$995M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$112M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$109M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.6% |
| 2 | Financials | 5.8% |
| 3 | Consumer Discretionary | 5.74% |
| 4 | Healthcare | 5.27% |
| 5 | Communication Services | 4.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Bank OZK
OZK
$5.72B
| $77.2K | ﹤0.01% |
2,567
+2,335
| +1,006% | +$72.4K |
|
3052
Century Communities
CCS
$2.01B
| $77.1K | ﹤0.01% |
2,900
-2,541
| -47% | -$67.3K |
|
|
ABTX
3053
DELISTED
Allegiance Bancshares
ABTX
| $76.9K | ﹤0.01% |
2,307
-158
| -6% | -$5.47K |
|
3054
NRC Health Common Stock
NRC
$469M
| $76.8K | ﹤0.01% |
1,333
-976
| -42% | -$45.2K |
|
|
UMPQ
3055
DELISTED
Umpqua Holdings Corp
UMPQ
| $76.6K | ﹤0.01% |
4,617
-89,377
| -95% | -$1.51M |
|
3056
Center Bancorp
CNOB
$1.79B
| $76.5K | ﹤0.01% |
3,374
-2,915
| -46% | -$62.8K |
|
|
TRUE
3057
DELISTED
TrueCar
TRUE
| $76.4K | ﹤0.01% |
13,997
-7,444
| -35% | -$45.6K |
|
3058
AstraZeneca
AZN
$243B
| $76.3K | ﹤0.01% |
924
-88
| -9% | -$6.9K |
|
|
GNC
3059
DELISTED
GNC Holdings, Inc.
GNC
| $76.2K | ﹤0.01% |
50,816
+2,140
| +4% | +$4.06K |
|
3060
Clearwater Paper
CLW
$345M
| $75.8K | ﹤0.01% |
4,100
-328
| -7% | -$6.14K |
|
3061
Prothena Corp
PRTA
$455M
| $75.8K | ﹤0.01% |
7,172
-3,889
| -35% | -$39.9K |
|
3062
Hanmi Financial
HAFC
$962M
| $75.7K | ﹤0.01% |
3,401
-2,932
| -46% | -$65K |
|
3063
First Mid Bancshares
FMBH
$1.38B
| $75.7K | ﹤0.01% |
2,168
-495
| -19% | -$16.8K |
|
3064
Argan
AGX
$8.11B
| $75.5K | ﹤0.01% |
1,861
-1,187
| -39% | -$55.6K |
|
|
LION
3065
DELISTED
Fidelity Southern Corporation
LION
| $75.4K | ﹤0.01% |
2,436
-2,128
| -47% | -$62.1K |
|
3066
National Beverage
FIZZ
$2.93B
| $75.2K | ﹤0.01% |
3,370
-18,346
| -84% | -$472K |
|
3067
Copa Holdings
CPA
$6.14B
| $74.9K | ﹤0.01% |
768
+30
| +4% | +$2.66K |
|
3068
MacroGenics
MGNX
$268M
| $74.3K | ﹤0.01% |
4,379
-3,780
| -46% | -$64.9K |
|
|
SRDX
3069
DELISTED
Surmodics
SRDX
| $74.3K | ﹤0.01% |
1,721
-1,041
| -38% | -$43.9K |
|
|
ALTA
3070
DELISTED
Altabancorp
ALTA
| $73.9K | ﹤0.01% |
2,512
-706
| -22% | -$20.3K |
|
3071
Par Pacific Holdings
PARR
$4.02B
| $73.9K | ﹤0.01% |
3,599
-3,072
| -46% | -$59.9K |
|
3072
Intellia Therapeutics
NTLA
$1.67B
| $73.8K | ﹤0.01% |
4,510
-3,138
| -41% | -$49.3K |
|
|
ACR
3073
ACRES Commercial Realty
ACR
$102M
| $73.8K | ﹤0.01% |
2,175
-147
| -6% | -$4.86K |
|
3074
Integra LifeSciences
IART
$1.43B
| $73.8K | ﹤0.01% |
1,321
-999
| -43% | -$51.4K |
|
3075
Preferred Bank
PFBC
$1.28B
| $73.7K | ﹤0.01% |
1,559
-1,342
| -46% | -$63K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2019 Portfolio in Review
As of Q2 2019, BNP Paribas Financial Markets held 4,663 positions worth $50.2B, up 8.5% from $46.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets's Q2 2019 filing shows 353 new, 1,075 increased, 2,687 reduced and 125 closed positions. Its largest new stake was Cigna: 315,599 shares worth $49.7M. The largest sale was Invesco QQQ Trust, an estimated $995M.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, up from 7.9% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2019 buy was Cigna: 315,599 shares worth $49.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $478M increase.
- BNP Paribas Financial Markets's biggest Q2 2019 reduction was Invesco QQQ Trust, cutting an estimated $995M.
- BNP Paribas Financial Markets fully exited ARRIS International plc Ordinary Shares in Q2 2019, selling an estimated $40.4M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $50.2B portfolio in Q2 2019.
- BNP Paribas Financial Markets opened 353 new positions and closed 125 in Q2 2019.
- BNP Paribas Financial Markets's portfolio value rose 8.5% quarter-over-quarter to $50.2B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2019, filed 30 Jul 2019.